perillyl alcohol has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anis, E; Fatima, M; Firdaus, F; Islam, SN; Mobarak Hossain, M; Zafeer, MF | 1 |
| Anis, E; Firdaus, F; Hossain, MM; Islam, SN; Khan, AA; Zafeer, MF | 1 |
2 other study(ies) available for perillyl alcohol and oxidopamine
| Article | Year |
|---|---|
Evaluation of phytomedicinal potential of perillyl alcohol in an in vitro Parkinson's Disease model.
Topics: Cell Line; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Humans; Membrane Potential, Mitochondrial; Monoterpenes; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Phytochemicals; Reactive Oxygen Species | 2018 |
Perillyl Alcohol Mitigates Behavioural Changes and Limits Cell Death and Mitochondrial Changes in Unilateral 6-OHDA Lesion Model of Parkinson's Disease Through Alleviation of Oxidative Stress.
Topics: Animals; bcl-2-Associated X Protein; Behavior, Animal; Caspase 3; DNA Fragmentation; Dynamins; Electron Transport Complex I; Electron Transport Complex IV; Enzyme Inhibitors; Mitochondria; Monoterpenes; Movement; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Proto-Oncogene Proteins c-bcl-2; Rats; Sympatholytics; Tyrosine 3-Monooxygenase | 2020 |